No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-α in threatened preterm labor

References

• World Health Organization. ICD-10 International statistical classification of diseases and related health problems10^th revision. World Health Organization, Geneva 1993; 2
   Google Scholar
• Blondel B, Norton J, du Mazaubrum C, Bréart G. Development of the main indicators of perinatal health in metropolitan France between 1995 and 1998. Results of the national perinatal survey. J Gynecol Obstet Biol Reprod (Paris) 2001; 30: 552–564
   PubMedGoogle Scholar
• Goldenberg R L. The management of preterm labour. Obstet Gynecol 2002; 100: 1020–1037
   PubMed Web of Science ®Google Scholar
• Verdenik I, Pajntar M, Leskošek B. Uterine electrical activity as predictor of preterm birth in women with preterm contractions. Eur J Obstet Gynecol Reprod Biol 2001; 95: 149–153
   PubMed Web of Science ®Google Scholar
• Greig P C, Murtha A P, Jimmerson C J, Herber W N, Roitman-Johnson B, Allen J. Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol 1997; 90: 465–469
   PubMed Web of Science ®Google Scholar
• Gücer F, Balkanli-Kaplan P B, Yüksel M, Yüce M A, Türe M, Yardim T. Maternal serum tumor necrosis factor-α in patients with preterm labor. J Reprod Med 2001; 46: 232–236
   PubMed Web of Science ®Google Scholar
• Mezad D, Hallak M, Huleihel M, Gortzak-Uzan L, Smolin A, Mazor M. Intravenous magnesium sulphate effect on maternal serum and amniotic fluid cytokines levels in preterm labour patients. Magnesium Res 2002; 15: 247–252
   PubMed Web of Science ®Google Scholar
• Bahar A M, Ghalib H W, Moosa R A, Zaki Z M, Thomas C, Nabri O A. Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor. Acta Obstet Gynecol Scand 2003; 82: 543–549
   PubMed Web of Science ®Google Scholar
• Carbonne B, Tsatsaris V. Which tocolytic drugs in case of preterm labor. J Gynecol Obstet Biol Reprod Paris 2002; 31(Suppl 7)5S96–5S104
   PubMedGoogle Scholar
• Verma U, Tejani N, Klein S, Reale M R, Beneck D, Figueroa R, Visintainer P. Obstetrical antecedents of intraventricular hemorrhage and periventricular leucomalacia in the low-birth-weight neonate. Am J Obstet Gynecol 1997; 176: 275–281
   PubMed Web of Science ®Google Scholar
• Ancel P Y. Perspective in the prevention of premature birth. Eur J Obstet Gynecol Reprod Biol 2004; 117S: S2–S5
   Google Scholar
• The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308–312
   PubMed Web of Science ®Google Scholar
• Kinslez V A, Thornton S, Ashford M L, Melin P, Smith S K. The effect of the oxytocin antagonists F 314 and F 792 on the in vitro contractility of human myometrium. Br J Obstet Gynaecol 1996; 103: 373–375
   PubMedGoogle Scholar
• Goodwin T M, Valenzuela G, Silver H, Hayashi R, Greasy G W, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996; 13: 143–146
   PubMed Web of Science ®Google Scholar
• Worldwide Atosiban versus Beta-agonist Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001; 108: 133–142
   PubMedGoogle Scholar
• Gomez R, Ghezzi F, Romero R. Premature labor and intra-amniotic infection. Clinical aspects, and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 1995; 22: 281–341
   PubMed Web of Science ®Google Scholar
• Alvarez-de-la-Rosa M, Rebollo F J, Codoceo R, Gonzalez Gonzalez A. Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. Eur J Obstet Gynecol Reprod Biol 2000; 88: 57–60
   PubMed Web of Science ®Google Scholar
• Salafia C M, Sherer D M, Spong C Y, Lenki S, Eglinton G S, Parkash V, Marley E, Lage J M. Fetal but not maternal serum cytokine levels correlate with histologic acute placental inflammation. Am J Perinatol 1997; 14: 419–422
   PubMed Web of Science ®Google Scholar
• Murtha A P, Greig P C, Jimmerson C E, Herbert W N. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol 1998; 91: 161–164
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Peaceman A M, Wigton T R, Rehnberg K A, Socol M L. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe pre-eclampsia. Am J Obstet Gynecol 1994; 170: 1752–1759
   PubMed Web of Science ®Google Scholar
• Blackwell S C, Hallak M, Hassan S S, Berry S M, Russell E, Sorokin Y. The effect of intrapartum magnesium sulphate on fetal serum interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha at delivery: A randomized, placebo-controlled trial. Am J Obstet Gynecol 2001; 184: 1320–1323
   PubMed Web of Science ®Google Scholar
• Schmid B, Wong S, Mitchell B F. Transcriptional regulation of oxytocin receptor by interleukin-1β and interleukin-6. Endocrinol 2001; 142: 1380–1385
   PubMed Web of Science ®Google Scholar
• Nowak M, Oszukowski P, Pieta A, Szpakowski M, Malafiej E, Malinowski A, Wierzbicka E, Drzazga W. The use of maternal serum cytokines in the predicting of the efficacy of tocolytic therapy in case of the threat of preterm labor. Ginekol Pol 1998; 69: 997–1002
   PubMedGoogle Scholar